ID: ALA37533

Max Phase: Preclinical

Molecular Formula: C17H15NO2

Molecular Weight: 265.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2c(c1)CC1NCCc3cc4c(c-2c31)OCO4

Standard InChI:  InChI=1S/C17H15NO2/c1-2-4-12-10(3-1)7-13-15-11(5-6-18-13)8-14-17(16(12)15)20-9-19-14/h1-4,8,13,18H,5-7,9H2

Standard InChI Key:  VZTUKBKUWSHDFM-UHFFFAOYSA-N

Associated Targets(non-human)

Mycobacterium sp. 32 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.31Molecular Weight (Monoisotopic): 265.1103AlogP: 2.83#Rotatable Bonds: 0
Polar Surface Area: 30.49Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 2.94CX LogD: 1.15
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.79Np Likeness Score: 1.73

References

1. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK..  (2017)  Drug development against tuberculosis: Impact of alkaloids.,  137  [PMID:28628823] [10.1016/j.ejmech.2017.06.005]

Source